The U.S. Supreme Court handed a victory to generic-drug companies, ruling they can file certain legal counterclaims against brand-drug companies in an effort to get their cheaper copycat medicines on the market.
Supreme Court sides with generic drugmakers
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.